Clinical and Radiographic Outcomes of the JointMedica Polymotion Resurfacing (PHR) Device

NCT ID: NCT07080671

Last Updated: 2025-07-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

105 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-25

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to generate Real World Evidence (RWE) on the device performance of the Polymotion Hip Resurfacing (PHR) system and its use in patients who have been implanted with the device for the treatment of hip osteoarthritis.

This study will assess the following endpoints:

* The survivorship of the Acetabular Cup (Kaplan-Meier estimate) through 2 years of follow-up.
* Radiographic success of the implanted cups, through quantitative motion analysis to assess migration of the acetabular cups.
* Absence of subsequent surgical intervention at the acetabulum of there operated hip.
* Absence of serious, device-related adverse events.
* Patient reported outcomes through Harris Hip Score and SUSHI - UCLA Hip Score questionnaires.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a retrospective and prospective study that will include a maximum of 70 patients who were implanted with the JointMedica Polymotion Hip Resurfacing (PHR) device in Canada, New Zealand and Australia.

Patients will be invited to consent to participate in this study, which will require their attendance of a follow-up standard of care visit to gather clinical data on the safety and performance of their index hip, undergo an x-ray imaging and complete two questionnaires to assess their functionality and outcomes.

Patient data will be entered into electronic data capture systems and x-rays will be submitted to a core imaging laboratory, MMI, for analysis to assess the state and position of their acetabular cup.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Real World Data Safety and Effectiveness Patient Reported Outcome (PRO)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient Group

The patient group is the entire group of patients who have been implanted with the Polymotion Hip Resurfacing (PHR) system. This is the only group in the study, all patients will be assessed under the same criteria.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 21 or above at the time of the surgery.
* Have had the Polymotion Hip Resurfacing (PHR) (implanted between September 2020 to January 2025
* Written informed consent given by subject
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

JointMedica Inc.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ronan Treacy

Role: PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mark Rickman

Adelaide, , Australia

Site Status

Gateway Surgery Centre

Calgary, Alberta, Canada

Site Status

Orthopaedic Specialist Centre

Auckland, , New Zealand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Australia Canada New Zealand

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Steve Meakins

Role: CONTACT

+441905978264

Oyin Akintomide

Role: CONTACT

+441905640008

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mark Rickman

Role: primary

+618 236 4135

James MacKenzie

Role: primary

(403) 910-4585

Hugh Blackley

Role: primary

+649 522 2980

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CI002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Persona Partial Knee Clinical Outcomes Study
NCT03034811 ACTIVE_NOT_RECRUITING NA
Emphasys Radiostereometric Analysis
NCT06173713 RECRUITING NA
Encore Revelation Hip Stem
NCT01514318 COMPLETED
Clinical Outcomes of Joint Arthroplasty
NCT03668691 ACTIVE_NOT_RECRUITING